Nextpower Inc. Total Cost of Revenue decreased by 6.1% to $583.14M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.7%, from $618.66M to $583.14M. Over 3 years (FY 2023 to FY 2026), Total Cost of Revenue shows an upward trend with a 14.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $303.84M | $400.86M | $353.37M | $402.60M | $431.11M | $428.08M | $365.80M | $424.25M | $500.70M | $396.05M | $482.48M | $410.78M | $438.46M | $618.66M | $582.53M | $612.41M | $621.22M | $583.14M |
| QoQ Change | — | +31.9% | -11.8% | +13.9% | +7.1% | -0.7% | -14.5% | +16.0% | +18.0% | -20.9% | +21.8% | -14.9% | +6.7% | +41.1% | -5.8% | +5.1% | +1.4% | -6.1% |
| YoY Change | — | — | — | — | +41.9% | +6.8% | +3.5% | +5.4% | +16.1% | -7.5% | +31.9% | -3.2% | -12.4% | +56.2% | +20.7% | +49.1% | +41.7% | -5.7% |